Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Avanos Medical, Inc. (AVNS)

Orthopedic, Prosthetic & Surgical Appliances & Supplies

https://www.avanos.com

Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. The firm operates in one segment, medical devices, which primarily sells products related to pain management, IV Therapy, and respiratory and digestive health. The company divides its Medical Devices segment into two franchises: Pain Management and Chronic Care. Pain Management provides non-opioid products for acute and interventional pain, including cold and compression therapy. Chronic Care aims at addressing digestive and respiratory issues with feeding tubes and catheters. Avanos generates most of its revenue from its Chronic Care franchise and in North America.

5405 WINDWARD PARKWAY, SUITE 100 SOUTH
ALPHARETTA, GA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/21/2014

Market Cap

1,070,611,700

Shares Outstanding

46,430,000

Weighted SO

46,425,569

Total Employees

N/A

Upcoming Earnings

08/14/2024

Similar Tickers

AORT --.--%

ANIK --.--%

SGHT --.--%

OFIX --.--%

AXGN --.--%

SRDX --.--%

FNA --.--%

GKOS --.--%

KIDS --.--%

Beta

0.9400

Last Div

0.0000

Range

17.235-24.77

Chg

0.2200

Avg Vol

211666

Mkt Cap

1070611700

Exch

NYSE

Country

US

Phone

844 428 2667

DCF Diff

26.5715

DCF

-3.3015

Div Yield

0.0000

P/S

1.5689

EV Multiple

12.8679

P/FV

0.8752

Div Yield %

0.0000

P/E

138.8922

PEG

-0.6224

Payout

0.0000

Current Ratio

2.2771

Quick Ratio

1.4899

Cash Ratio

0.4428

DSO

65.7899

DIO

200.0117

Op Cycle

265.8016

DPO

62.7248

CCC

203.0767

Gross Margin

0.5617

Op Margin

0.0687

Pretax Margin

0.0205

Net Margin

0.0113

Eff Tax Rate

0.5000

ROA

0.0046

ROE

0.0063

ROCE

0.0324

NI/EBT

0.5500

EBT/EBIT

0.2985

EBIT/Rev

0.0687

Debt Ratio

0.1143

D/E

0.1551

LT Debt/Cap

0.1189

Total Debt/Cap

0.1343

Int Coverage

5.8625

CF/Debt

0.3251

Equity Multi

1.3566

Rec Turnover

5.5480

Pay Turnover

5.8191

Inv Turnover

1.8249

FA Turnover

4.8708

Asset Turnover

0.4116

OCF/Share

1.3420

FCF/Share

0.9107

Cash/Share

2.0087

OCF/Sales

0.0903

FCF/OCF

0.6786

CF Coverage

0.3251

ST Coverage

2.5041

CapEx Coverage

3.1111

Div&CapEx Cov

3.1111

P/BV

0.8752

P/B

0.8752

P/S

1.5689

P/E

138.8922

P/FCF

25.6127

P/OCF

17.3615

P/CF

17.3615

PEG

-0.6224

P/S

1.5689

EV Multiple

12.8679

P/FV

0.8752

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Oct 06, 23:30 Bio Pharma Buffer Market to Reach $2.4 Billion, Globally, by 2033 at 7.8% CAGR: Allied Market Research

Revenue Product Segmentation